Fig 1.
Database construction steps.
Table 1.
Concentration level estimates for the mAbs and chemical drug innovations markets.
Fig 2.
Log-log estimation of the holder’s participation in total patents and priorities.
Fig 3.
Participation of different holder types in technology development.
Fig 3A = participation of different holder types in technology development in the market for mAbs; Fig 3B = participation of different holder types in technology development in the market for chemical drug.
Fig 4.
Cumulative distribution functions comparing the market for mAb and chemical drug innovations regarding the time between the priority and progeny patents deposit.
Fig 5.
Log-log estimation of the partnerships for the creation of patents and priorities.
Table 2.
Number of holder types registered as patent and priority holders.
Fig 6.
Priorities associated with developing medicines according to the holder.